Variable cytotoxicity of diphtheria toxin 388-granulocyte-macrophage colony-stimulating factor fusion protein for acute myelogenous leukemia stem cells

Experimental Hematology

Volumn 28, Issue 12, 2000, Pages 1390-1400

  Feuring Buske, Michaela ^a   Frankel, Arthur ^b   Gerhard, Brigitte ^a   Hogge, Donna ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

AML; DT388 GM CSF; Immunotherapy; Stem cell

Indexed keywords

DIPHTHERIA TOXIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYBRID PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL STRAIN HL 60; COLONY FORMING CELL; CONTROLLED STUDY; CYTOTOXICITY; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOPOIESIS; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL;

ANIMALS; BONE MARROW; BONE MARROW PURGING; CELL DEATH; CYTOGENETIC ANALYSIS; DIPHTHERIA TOXIN; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOCYTIC, ACUTE; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM TRANSPLANTATION; RECEPTORS, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; RECOMBINANT FUSION PROTEINS; SPLEEN; TUMOR CELLS, CULTURED;

EID: 0034537062     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(00)00542-7     Document Type: Article

References (48)

1. Acute myeloid leukemia
2. Role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia
3. - cases
4. MDR1 gene expression and treatment outcome in acute myeloid leukemia
5. Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia
6. Association of bcl-2, bax, bcl-xL and interleukin-1 β-converting enzyme expression with initial response to chemotherapy in acute myeloid leukemia
7. The relationship between bcl-2 expression and response to chemotherapy in acute leukaemia
8. MDR1 reversal; criteria for clinical trials designed to overcome the multidrug resistance phenotype
9. Combination of quinine as a potential reversing agent with mitoxantrone and cytarabine for the treatment of acute leukemias; a randomized multicenter study
10. Interleukin-3 and granulocyte-monocyte colony-stimulating factor receptors on human acute myelocytic leukemia cells and relationship to the proliferative response
11. + cells and leukemic cell lines
12. Granulocyte-macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology
13. + bone marrow cells, differentiating monomyeloid progenitors, and mature blood cell subsets
14. Modulation of the apoptotic response of human myeloid leukemia cells to a diphtheria toxin granulocyte-macrophage colony-stimulating factor fusion protein
15. Malignant progenitors from patients with acute myelogenous leukemia are sensitive to a diphtheria toxin-granulocyte-macrophage colony-stimulating factor fusion protein
16. Detection and characterization of primitive malignant and normal progenitors in patients with acute myelogenous leukemia using long-term coculture with supportive feeder layers and cytokines
17. Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic/severe combined immunodeficient mice
18. Characterization of a hierarchy in human acute myeloid leukemia progenitor cells
19. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
20. Expression of Hox genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells
21. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers
22. + subpopulations of human bone marrow cells
23. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice
24. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice
25. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group
26. Enhanced detection, maintenance and differentiation of primitive human hematopoietic cells in cultures containing murine fibroblasts engineered to produce human Steel factor, interleukin-3 and granulocyte colony-stimulating factor
27. Alternative mechanisms with and without Steel factor support primitive human hematopoiesis
28. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice
29. Retroviral marking of acute myelogenous leukemia progenitors that initiate long-term culture and growth in immunodeficient mice
30. Cell-specific modulation of drug resistance in acute myeloid leukemic blasts by diphtheria fusion toxin, DT388-GM-CSF
31. Sensitivity of human acute myeloid leukaemia to diphtheria toxin-GM-CSF fusion protein
32. Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor eliminates acute myeloid leukemic cells with the potential to initiate leukemia in immunodeficient mice, but spares normal hemopoietic stem cells
33. Autologous bone marrow transplantation in acute leukemia; a phase I study of in vitro treatment of marrow with 4-hydroperoxycyclophosphamide to purge tumor cells
34. Efficient retroviral-mediated gene transfer to human cord blood stem cells with in vivo repopulating potential
35. Toxicology and pharmacokinetics of DTGM, a fusion toxin consisting of a truncated diphtheria toxin (DT388) linked to human granulocyte-macrophage colony-stimulating factor, in cynomolgus monkeys
36. -
37. Targeted toxin therapy for the treatment of cancer
38. Combination immunotoxin treatment and chemotherapy in SCID mice with advanced, disseminated Daudi lymphoma
39. Anti-B4-blocked ricin synergizes with doxorubicin and etoposide on multidrug-resistant and drug-sensitive tumors
40. Combined immunochemotherapy of human solid tumors in nude mice
41. Alkylating agents and immunotoxins exert synergistic cytotoxic activity against ovarian cancer cells. Mechanism of action
42. Marrow purging in autologous bone marrow transplantation for T-lineage acute lymphoblastic leukemia; efficacy of ex vivo treatment with immunotoxins and 4-hydroperoxycyclophospham row progenitor cells
43. Effective immunochemotherapy of human t(4;11) leukemia in mice with severe combined immunodeficiency (SCID) using B43 (anti-CD19)-pokeweed antiviral protein immunotoxin plus cyclophosphamide
44. Chemoimmunotoxin therapy against a human colon tumor (HT-29) xenografted into nude mice
45. Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor and Ara-C exert synergistic toxicity against human AML HL-60 cells